WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene, leading developer of AI models for tumor and immune biology, today announced its participation at the 22nd Annual Industry/Academia Precision Oncology & RadMed Symposium. At this premier event, global leaders in life sciences will explore the latest innovations in AI, immuno-oncology, molecular imaging, and targeted therapies. The symposium will be held on Thursday, June 11, 2026, at The Alexandria at Torrey Pines Conference Center in San Diego,
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
